CAR Selectively Enhances the Pulmonary Vasodilatory Effect of Fasudil in a Microsphere Model of Pulmonary Hypertension

BACKGROUND: Despite the approval of several medications for pulmonary hypertension, morbidity and mortality are unacceptably high. Systemic hypotension may limit the use of pulmonary hypertension medications. OBJECTIVES: This study aimed to assess whether the homing peptide CAR (CARSKNKDC) improves...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothman, Abraham, Restrepo, Humberto, Evans, William N., Sarukhanov, Valeri, Mann, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351346/
https://www.ncbi.nlm.nih.gov/pubmed/37916136
http://dx.doi.org/10.2174/18743064-v17-e230404-2022-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351346/
https://www.ncbi.nlm.nih.gov/pubmed/37916136
http://dx.doi.org/10.2174/18743064-v17-e230404-2022-19

Ejemplares similares